角膜替代模型在眼科安全测试与疗效研究中的新进展:聚焦器官芯片、类器官与3D模型
综述指出,传统2D细胞培养与动物模型存在关键局限,而3D组织工程构建、器官芯片、角膜类器官及生物打印等替代角膜模型能更好地重现天然角膜的多层结构、生物力学特性、流体动力学与细胞微环境。这些模型有助于更准确地研究药物渗透、毒性、伤口愈合与疾病机制,并与NIH推动的替代、减少、优化动物研究及新方法学(NAMs)倡议一致。
要点
- 3D组织工程、器官芯片、类器官与生物打印等替代角膜模型提高生理相关性与转化价值。
- 角膜芯片整合微流控以模拟泪流、眨眼与生物力学力。
- 多能干细胞来源的角膜类器官提供自组织、人源特异性平台用于疾病建模与安全评估。
核心结论
- 替代性新兴角膜模型支持伦理科学、提高转化准确性并满足联邦法规要求,同时减少动物测试。
研究设计与样本
- 综述首先概述传统体内与体外角膜模型以提供历史背景及其局限性,随后讨论下一代技术。
主要发现
- 先进模型更好地重现天然角膜的多层结构、生物力学特性、流体动力学与细胞微环境。
- 角膜芯片系统整合微流控以代表泪流、眨眼与生物力学力。
- 角膜类器官源自多能干细胞,提供自组织、人源特异性平台用于疾病建模与安全评估。
- 3D生物打印进展使得能够制造机械可调的角膜构建体。
- 综述强调生物信息学/人工智能在预测眼部反应和补充实验平台方面的重要性。
临床怎么用
- 这些替代模型可用于更准确地研究药物渗透、毒性、伤口愈合与疾病机制。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Accurate assessment of ocular toxicity, drug safety, and therapeutic efficacy remains a significant challenge due to the complex anatomy and physiology of the human cornea. Furthermore, conventional two-dimensional (2D) cell cultures and animal models have key limitations. Recent advances in alternative corneal models-three-dimensional (3D) tissue-engineered constructs, organ-on-chip platforms, corneal organoids, and bio-printed systems have transformed ophthalmic research by offering improved physiological relevance and translational value. These advanced models better recapitulate the multilayered architecture, biomechanical properties, fluid dynamics, and cellular microenvironment of the native cornea, enabling more accurate investigation of drug penetration, toxicity, wound healing, and disease mechanisms. In alignment with current National Institutes of Health (NIH) initiatives promoting the replacement, reduction, and refinement of animal research and the promotion of New Approach Methodologies (NAMs), this review examines emerging corneal models that collectively represent a paradigm shift in ophthalmic research. We first outline conventional in vivo and in vitro corneal models to provide historical context and their limitations, followed by a discussion of next-generation technologies. These include cornea-on-chip systems that integrate microfluidics to represent tear flow, blinking, and biomechanical forces; corneal organoids derived from pluripotent stem cells that offer self-organizing, human-specific platforms for disease modeling and safety assessment; and advances in 3D bioprinting enabling the fabrication of mechanically adjustable corneal constructs. The review also highlights the importance of bioinformatics/artificial intelligence in predicting ocular responses and complementing experimental platforms. Collectively, we emphasize that these alternative, emerging technologies support ethical science, improve translational accuracy, and meet federal regulations while reducing animal testing.
引用
- Stambersky A, Rajak SK, Bajpai M, et al. Recent advances in alternate corneal models for ophthalmic safety testing and efficacy studies: A special focus on organ-on-a-chip, organoid, and 3D models. Prog Retin Eye Res. 2026. PMID: 42767443. doi:10.1016/j.preteyeres.2026.101530
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。